Glucocorticoids and checkpoint tyrosine kinase inhibitors stimulate rat pancreatic beta cell proliferation...

Area of Science:

• Endocrinology
• Cell Biology
• Molecular Biology

Background:

• Cell therapy for diabetes requires methods to increase functional pancreatic beta cells.
• Glucocorticoids were previously identified as potent stimulators of beta cell proliferation.

Purpose of the Study:

• To compare the beta cell proliferation-stimulating effects of glucocorticoids with checkpoint tyrosine kinase inhibitors.
• To analyze the impact of these compounds on DNA synthesis, cell numbers, and cell cycle regulators.

Main Methods:

• Utilized a screening assay to identify beta cell proliferation stimulants.
• Administered glucocorticoids and checkpoint kinase inhibitors to beta cells.
• Measured DNA synthesis, absolute cell numbers, and expression of cell cycle regulators.
• Used mifepristone (glucocorticoid receptor antagonist) to assess signaling duration.

Main Results:

• Glucocorticoids induce beta cells to pass the cell cycle restriction point within 48 hours, committing them to division.
• Glucocorticoids stimulate up to 75% of beta cells to undergo mitosis within 14 days, acting as proliferation competence-inducing factors.
• Checkpoint kinase inhibitors stimulate DNA synthesis transiently in a small cell fraction, without increasing overall beta cell numbers.
• Glucocorticoids, but not kinase inhibitors, alter the expression of checkpoint regulators, implicating Chk1 and Cdk1 in glucocorticoid-induced beta cell cycle progression.

Conclusions:

• Glucocorticoids are effective proliferation competence-inducing factors for pancreatic beta cells, essential for cell therapy development.
• Checkpoint kinase inhibitors are less effective than glucocorticoids in promoting beta cell proliferation and increasing cell numbers.
• Glucocorticoids modulate cell cycle regulators, highlighting specific pathways (Chk1, Cdk1) involved in beta cell division.